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Abstract
The contribution of the Wnt signaling pathway to HPV-induced carcinogenesis is poorly
understood. In high-grade dysplastic lesions that are caused by high-risk human papilloma viruses
(HR-HPVs), β-catenin is often located in the cell nucleus, which suggests that Wnt pathway may
be involved in the development of HPV-related carcinomas. Most of the oncogenic potential of
HR-HPVs resides on the E6 protein’s PDZ-binding domain. We hypothesized that the PDZ-
binding domain of the HPV16-E6 oncoprotein induces the nuclear accumulation of β-catenin due
to its capacity to degrade PDZ-containing cellular targets. To test this hypothesis, we evaluated the
staining pattern of β-catenin in the skin epidermis of transgenic mice expressing the full-length E6
oncoprotein (K14E6 mice) and measured LacZ gene expression in K14E6 mice that were crossed
with a strain expressing LacZ that was knocked into the Axin2 locus (Axin2+/LacZ mice). Here, we
show that the E6 oncoprotein enhances the nuclear accumulation of β-catenin, the accumulation of
cellularβ-catenin-responsive genes and the expression of LacZ. None of these effects were
observed when a truncated E6 oncoprotein that lacks the PDZ-binding domain was expressed
alone (K14E6ΔPDZ mice) or in combination with Axin2+/LacZ. Conversely, co-transfection with
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either E6 or E6ΔPDZ similarly enhanced canonical Wnt signaling in short-term in vitro assays that
utilized a luciferase Wnt/β-catenin/TCF-dependent promoter. We propose that the activation of
canonical Wnt signaling could be induced by the HPV16-E6 oncoprotein; however, the
participation of the E6 PDZ-binding domain seems to be important in in vivo models only.
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Introduction
Human papillomaviruses (HPVs) are small DNA tumor viruses that cause the formation of
warts and papillomas in several stratified epithelia such as those of the skin, genitalia and
upper respiratory tract (1). Epidemiological and experimental data have shown that the
“high-risk” HPVs (HR-HPVs), such as type 16 and 18, contribute to HPV-related cancer
development (2). These HR-HPVs owe their oncogenic potential to the constitutive
expression of the E6 and E7 oncogenes whose products enhance cell proliferation and
perturb cell differentiation through several mechanisms (3). E7 promotes cell proliferation
by associating with the tumor suppressor pRb and other cell cycle regulatory proteins (4),
and E6 binds to and inactivates p53 tumor suppressor protein and several proteins that
participate in cell-cell adhesion (5).
The progression of HPV-related cancers clearly involves dysplastic lesions that are caused
by the E6 and E7 oncoproteins; nevertheless, some of the molecular events that are regulated
by these oncoproteins are not fully understood (3). To date, cell culture experiments have
demonstrated that the exogenous expression of HR-E6 proteins induces the immortalization
of human mammary epithelial cells (6). Furthermore, transgenic mice that express the
HPV16-E6 oncoprotein in the basal stratified epithelium under the control of the human
keratin 14 promoter (K14E6 mice) develop papillomas and cancer of the skin epidermis (7).
The in vivo tumor-capacity of E6 is dramatically reduced when a truncated version of E6
that lacks the PDZ-binding domain (K14E6ΔPDZ transgenic mice) is expressed in the basal
stratified epithelium of transgenic mice (8). Although p53 is the most studied cellular target
of E6, its participation in skin carcinogenesis seems to be minor in comparison with other
E6 cellular targets, such as those that contain PDZ domains (7, 8). Recent experimental
evidence suggests that the canonical Wnt signaling pathway may play a key role in E6’s
oncogenic potential (9).
Wnt ligands control several differentiation processes during normal tissue homeostasis (10,
11), and they are implicated in pathological conditions such as in certain types of cancer (12,
13). In the absence of Wnt ligands, β-catenin forms a “degradation complex” with kinases
and scaffold proteins, such as Glycogen Synthase Kinase-3β (GSK3β), Casein Kinase 1 and
2 (CK1 and CK2), Adenomatous Polyposis Coli (APC) and Axin2. This degradation
complex phosphorylates β-catenin at serine and threonine residues inducing its
ubiquitination by β-TcRP ubiquitin ligase and degradation. The activation of canonical Wnt
signaling induces the phosphorylation of the intracellular Dishevelled (Dvl) protein, which
eventually interacts with Axin2 and impedes the formation of the β-catenin degradation
complex; this process leads to the accumulation and nuclear translocation of β-catenin. Once
it is translocated into the nucleus, β-catenin binds members of the TCF/LEF family of
transcription factors, of which T-cell factor 4 (TCF4) is the best characterized. β-catenin-
TCF4 complexes control the expression of several target genes that regulate cell polarity,
proliferation and differentiation (12) including c-jun (13), c-myc (14), cyclin D1 (15),
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multidrug resistance 1 (16), matrilysine (17), Axin2 (18) and survivin (13) and others
(http://www.stanford.edu/~rnusse/pathways/targets.html).
The participation of canonical Wnt pathway in cervical cancer is evident because the nuclear
accumulation of β-catenin correlates with tumor progression in human patients (19). Nuclear
β-catenin is commonly found in human HPV16-positive invasive carcinoma biopsies, but it
is uncommon in early dysplastic lesions (20–22). In addition, recent in vitro evidence
supports the hypothesis that HR-E6 alone can enhance canonical Wnt signaling (9).
In this study, we present for the first time in vivo evidence supporting the hypothesis that the
HR-E6 protein enhances canonical Wnt signaling. However, the importance of the E6 PDZ-
binding domain remains controversial, while it is necessary for Wnt pathway activation in
transgenic mice, it is not required in cultured COS7 cells or primary keratinocytes,
indicating that other factors present in mice are required for Wnt signaling activation.
Materials and Methods
K14E6, K14E6ΔPDZ and Axin2+/LacZ mice and sample isolation
The construction of transgenic mice containing the full version of the HPV16-E6 oncogene
(K14E6), the truncated version lacking the PDZ-binding domain (K14E6Δ146-151 or
K14E6ΔPDZ), and the knock-in of Axin2+/LacZ has been described previously (7, 8, 23).
The mice were housed and treated according to the American Association of Laboratory
Animal Care (AALAC) regulations, and the research protocols were approved by the
Research Unit for Laboratory Animal Care Committee (UPEAL-CINVESTAV-IPN,
Mexico; NOM-062-ZOO-1999). Skin biopsies from the transgenic strains and FvB non-
transgenic mice (NTG) were resected, fixed and paraffin-embedded for the histological
procedures, or they were immediately frozen in liquid nitrogen for protein or RNA isolation
(Trizol method). For the histological procedures (immunohistochemistry (IHC) and
Immunofluorescence (IF)), five-micrometers-thick transversal sections were mounted on
charged microscope slides (Fisher Scientific, U.S.A.) for immunohistochemistry (IHC), or
immunofluorescence (IF) techniques.
Immunohistochemistry (IHC) and Immunofluorescence (IF) procedures
The skin sections were de-paraffinized and rehydrated as described previously (7). The
protein detection for IHC was performed using the Mouse/Rabbit PolyDetector HRP/DAB
Detection System (Bio SB, U.S.A.) according to manufacturer’s recommendations. The
samples were incubated overnight with primary antibodies against PCNA, p53, Dlg1 or
Scribble primary antibodies (Santa Cruz Biotechnology, U.S.A.) diluted at 1:100. Following
the IHC procedures, the tissues were counterstained with hematoxylin and mounted in
GVA-mount reagent (Zymed, U.S.A.). For the IF procedures, the skin sections were rinsed
in 1X PBS and blocked for 2 hours at 4oC with 1X PBS that was supplemented with 0.3%
Triton X-100 and 1% BSA; they were washed three times with 1X PBS and incubated for 1
h at 37°C with an anti-β-catenin antibody (Santa Cruz Biotechnology, U.S.A.). The sections
were then incubated with a FITC-labeled secondary antibody (Zymed, U.S.A.) for 30 min at
room temperature; they were rinsed above, counterstained with Propidium Iodide and
mounted in Vectashield (Vector, Burlingame, CA). The preparations were examined by
confocal microscopy using an SP2 (Leica Microsystems, Wetzlar, Germany). Captured
images were imported into the ImageJ software program (version 1.37v, National Institutes
of Health, Bethesda, MD) to produce maximum projections, and Adobe Photoshop (Adobe
Systems, Mountain View, CA) was used to equalize the brightness and contrast in all of the
images. The positive signals in the IHC and IF images were quantified from four different
animals per experiment (Amplification 40X; 3 sections per mouse) using the Image-Pro Plus
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7.0 software program (Media Cybernetics, U.S.A.) and “t student” statistical test (*p<0.05,
**p<0.01 and ***p<0.001) were performed using the SPSS 13.0 software package (IBM,
U.S.A.).
Wnt-responsive Axin2+/LacZ mice assays
Axin2+/LacZ mice were crossed to NTG, K14E6, or K14E6ΔPDZ mice. Skin tissues were
resected from the resulting 7-month-old double transgenic mice and immediately embedded
in paraffin for the histological procedures. The skin sections were fixed (0.5%
glutaraldehyde, 1.25 mM EGTA and 2 mM MgCl2 in 1X PBS, pH=7.3), washed with 1X
PBS that contained detergents (0.01% sodium deoxycholate and 0.02% Igepal CA-630) and
2 mM MgCl2, and then incubated in LacZ staining buffer (0.6 mg/ml X-gal, 4 mM
potassium ferrocyanide and 4 mM potassium ferricyanide in wash buffer). The tissues were
subsequently counter stained with Nuclear Fast Red and mounted with Permount.
Relative mRNA quantification by RT-qPCR and data analysis using the 2−ΔΔCT method
Real-time qPCR was performed using a LightCycler 2.0 apparatus (Roche, Germany) and a
DNA Master SYBR Green I Kit (Roche, U.S.A.). The templates were amplified in 45 cycles
of a 3-step PCR process, which included a 30-s of denaturation step at 95°C, a 30-s primer-
dependent annealing phase (60°C), and a 30-s template-dependent elongation at 72°C. The
amplification of each template was performed in duplicate in one PCR run. The differential
expression of the investigated genes was calculated as a ratio normalized to GAPDH gene
expression. The data were analyzed using the equation that was previously described by
Livak (24) (amount of target = 2−ΔΔCT).
Luciferase assays
COS7 cells were plated in 12-well tissue culture plates and grown for 24 hr. The cells were
then co-transfected with either E6, E6ΔPDZ (aa146-151 deleted), E7, Dvl2 (in the pCS2
vector that included a Flag tag and was kindly provided by Dr. Jeff Rubin), β-catenin S37A
(pFlagCMV2, which was kindly provided by Dr. Stephen Byers) or the empty vector control
alone or together with Super8XTOPFlash (which contains eight copies of TCF/LEF-binding
sites upstream of the luciferase gene and was kindly provided by Dr. Randall Moon) and the
Renilla-TK construct (transfection control, which was kindly provided by Dr. Stephen
Byers) using FuGENE6 according to the manufacturer’s instructions (Roche Applied
Science, Mannheim, Germany). All of the E6- and E7-gene-related constructs were cloned
into pJS55 vector and tagged with an AU1 epitope at the C-terminus. The Dual-Luciferase
Reporter assay was performed 24 h after the transfection according to the manufacturer’s
protocol (Promega, U.S.A.).
Immunoprecipitation
COS7 cells were cotransfected with either: Dvl2, E6, E6ΔPDZ or the empty vector alone or
together by using FuGENE6. Twenty-four hours after transfection the cells were lysed with
phospholysis buffer (50 mM Hepes, pH 7.9, 100 mM NaCl, 4 mM NaPP, 10 mM EDTA, 10
mM NaF, 1% TritonX100, fresh 2 mM fresh vanadate, 1 mM PMSF, 2 μg/mL aprotinin and
2 μg/mL leupeptin). One milligram of the protein lysate protein was subjected to overnight
immunoprecipitation with an anti-Dvl2 antibody (Santa Cruz, U.S.A.) and this was followed
with a 1-h incubation with protein G agarose beads (Invitrogen, U.S.A.). The
immunoprecipitates were subjected to SDS/PAGE and transferred to an Immobilon-P
membrane (Millipore). The membrane was blocked in 5% nonfat dry milk in 1X TBS (20
mM Tris-HCl pH 7.5, 150 mM NaCl and 0.5% Tween-20) for 2 h, blotted with an anti-Dvl2
(1:1000) or anti-AU1 (1:1000; Convance, U.S.A.) primary antibody overnight, and then
incubated with an HRP-linked anti-mouse or anti-rabbit secondary antibody (GE
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Healthcare) for 1 h. The membranes were developed using the Millipore Immobilon
Western Chemiluminescent HRP Substrate according to the manufacturer’s instructions.
Chemiluminescense was detected using a Fujifilm LAS-3000 imaging system.
Results
The E6’s PDZ-binding domain is required to maintain skin hyperplasia in adult transgenic
mice
K14E6 and K14E6ΔPDZ mice were previously reported to express the complete and
truncated E6 oncoprotein in the basal layer of stratified epithelia, respectively (7, 8).
However, of the two transgenic strains, only the K14E6 mice developed skin hyperplasia
and skin cancer at advanced ages (7, 8). Based on this observation, we first compared the
cell proliferation pattern in the skin epidermis for the E6 transgenic strains and the NTG
mice at juvenile and adult ages (Figure 1A).
The Immunostaining of PCNA, a cell proliferation marker shows, that cell proliferation at a
young age was quite similar in the K14E6 and K14E6ΔPDZ mice. However, unlike the
K14E6ΔPDZ or NTG mice, only the K14E6 adult mice retained suprabasal cell proliferation
(Figure 1A). It was previously reported that both transgenic E6 strains display equally
diminished p53 protein expression in adult animals (8). We also found that both of the
transgenic strains can degrade the p53 protein in younger animals after ultraviolet light
irradiation (Figure 1B). Therefore, the cell proliferation differences between the two
transgenic strains are not related to differences in p53 degradation.
To test the functionality of the E6’s PDZ-binding domain in adult mice, we examined the
levels of Dlg1 and Scribble (Scrib), which are two well-described PDZ-cellular-targets of
HR-E6. Importantly, these targets participate processes such as cell-cell junction formation
and canonical Wnt signaling activation (25). We observed that the K14E6 mice displayed
lower levels of both cellular proteins compared to the K14E6ΔPDZ counterpart and NTG
mice (Figure 2). Therefore, it is possible that the oncogenic effects that were observed in the
adult skin epidermis of the K14E6 mice could be partially related, in part, to cellular
processes regulated by those PDZ-containing targets including the Wnt pathway.
The E6’s PDZ-binding domain induces nuclear β-catenin protein accumulation and
enhances Wnt signaling pathway
To evaluate whether canonical Wnt signaling is activated by the E6 PDZ-binding domain,
we detected β-catenin in skin slices from mice at different ages. In eight-day-old mice, β-
catenin was not apparent in the cell nucleus; however, from the age of four months onward,
an increased amount of β-catenin level was detected in the nuclei of the K14E6 mice and the
most pronounced accumulation was observed in 1-year-old mice (Figure 3A). We next
asked whether the nuclear β-catenin detected in the skin epidermis of adult mice was
transcriptionally active. Axin2 is a negative feedback regulator of the Wnt pathway and is
expressed in response to Wnt signaling (26). The insertion of the LacZ gene into the Axin2
locus (Axin2+/LacZ mice) mimics the expression pattern of Axin2, but it does not lead to a
detectable axin-deficient phenotype in the heterozygous state (27). Therefore, we crossed
Axin2+/LacZ mice with either K14E6, K14E6ΔPDZ or control NTG mice to measure Wnt
signaling activity in adult skin samples. LacZ was expressed more strongly in the skin
epidermis of the Axin2+/LacZ/K14E6 double transgenic mice compared to the Axin2+/LacZ/
K14E6ΔPDZ or Axin2+/LacZ/NTG mice (Figure 3B). We also measured the mRNA levels of
three well-described β-catenin targets that participate in cell cycle progression or cell
survival c-myc, Birc5 and ccnd1 genes in adult skin. As shown in Figure 4A, the mRNA
induction of these targets genes was enhanced in adult skin tissue of the K14E6 mice
compared to the K14E6ΔPDZ mice. c-Myc expression was also validated by RT-PCR and
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Western blotting (Figure 4B). Therefore, we concluded that Wnt signaling may be enhanced
in vivo by the HPV16-E6 oncogene, and that the PDZ-binding domain plays an important
role in this induction.
The E6 oncoprotein associates with Dvl2 and induces canonical Wnt signaling in vitro
independently of the PDZ-binding domain in vitro
To analyze Wnt signaling induction in an in vitro system, we transiently transfected COS7
cells with a well-established functional assay vector that contains several copies of the TCF-
binding site and regulates a luciferase reporter gene (the TOPFLASH construct). The
transfection of the HPV16-E6 expression vector alone results in the minimal expression of
the TOPFLASH vector; however, the combination of HPV16-E6 and a Wnt signaling
inducer, such as β-catenin or Dvl2 (the Dvl isoform that is preferentially expressed in the
skin) clearly enhances TOPFLASH activity (Supplemental Figure 1). Interestingly, only
transfected HPV16-E6, but not HPV16-E7 cooperates with β-catenin or Dvl2 to trigger
TOPFLASH induction (Supplemental Figure 1).
To determine whether the E6 PDZ-binding domain is involved in Wnt pathway induction in
vitro, we co-transfected COS7 cells with constructs expressing the complete HPV-E6
protein, or a truncated version lacking the last 6 amino acids which comprise the PDZ-
binding domain. In contrast to our in vivo observations, and consistent with the report of
Lichtig et al. data (9), both versions of the E6 oncoprotein cooperated with β-catenin or
Dvl2 and induced Wnt signaling (Figure 5A). We also performed these in vitro experiments
with primary human foreskin keratinocytes and obtained similar results to those that were
observed in the COS7 cells (Supplemental Figure 2).
Dvl proteins play a central role in the regulation of both canonical and non-canonical Wnt
signaling. There are three Dvl isoforms in mammals (28), all them containing PDZ domains
(29). Because E6 contains a PDZ-binding domain, it was possible to consider a possible
PDZ-connection with Dvl isoforms. To test this possibility, we immunoprecipitated E6 and
blotted against the three Dvl isoforms (and vice versa) E6 co-immunoprecipitated E6 with
the Dvl2 protein but not with the Dvl1 or 3 isoforms (Supplemental Figure 3) which
suggests that the E6 oncoprotein preferentially binds the Dvl isoform that is expressed in the
skin (30). We next tested the ability of E6 to interact with the Dvl2 protein via its PDZ-
domain using the E6 or E6ΔPDZ expression vectors. Interestingly, both of the E6
oncoproteins co-immunoprecipitated with Dvl2 (Figure 5B), which suggests the presence of
a PDZ-independent interaction. Therefore, E6 proteins that contain or lack the PDZ domain
could enhance Wnt signaling and interact with the Dvl2 protein in short-term in vitro assays.
Discussion
The K14E6 mouse strains has been established as a model of papilloma-induced skin cancer
(7). In this model, the expression of the HPV16-E6 oncogene was directed to the basal layer
of stratified epithelia which includes the skin epidermis, lens and cervical tissue, among
others (7, 31). Although E6 is virtually expressed in all stratified epithelia, it only develops
spontaneous dysplasias or tumors in the skin epidermis (not in other tissues such as the
cervix) (32, 33), which suggests that tissue-specific factors are critical for mediating the
oncogenic potential of E6 (7, 8, 33). In an attempt to explain discrepancies that occur due to
tissue type, we recently reported the global gene-expression differences in the skin
epidermis and cervical tissue in adult K14E6 mice (33). We found that the expression of
genes that participate in cell adhesion and Wnt signaling were preferentially altered in the
skin epidermis compared to the cervical tissue (33). Based on these observations, we used
the skin epidermis of K14E6 mice as a functional model to study the relationship between
the E6 oncoprotein and Wnt signaling.
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The in vivo data that were obtained with the K14E6ΔPDZ mouse model suggests that E6’s
oncogenic potential in skin epidermis relies on its PDZ-binding domain (8, 34). In this
study, we show that although K14E6 and K14E6ΔPDZ mice have a quite similar
hyperproliferative skin phenotype at eight days of age (Figure 1A) only K14E6 mice retain
the hyperproliferative skin phenotype, at four months of age, which suggests that E6’s early
hyperproliferative effects on the skin are independent of the PDZ-binding domain. However,
the PDZ-binding domain is indeed required to maintain suprabasal cell proliferation in adult
mice (Figure 1).
Most of the previous studies regarding HPV-positive cervical lesions support the view that
Wnt signaling represents a late-stage step in cervical carcinogenesis and that other factors
are needed to activate this pathway (19–22, 35). Unlike its role in cervical tissues, E6 is
sufficient to induce skin papillomas and cancer in K14E6 mice (7); however, similarly as to
cervical tissue, Wnt signaling occurs only after PDZ-independent hyperproliferation. As
demonstrated in Figure 3A, the adult K14E6 animals accumulated β-catenin in their skin-
cell nuclei but the precise mechanism by which E6 enhances Wnt pathway is beyond the
scope of this study. A possible mechanism by which E6 induces Wnt pathway activation
may involve its effects on cellular targets that containin PDZ domains such as Dlg1 and
Scribble. It is well-known that Dlg1 and Scribble proteins (both containing PDZ domains)
participate in the zonula adherens formation (36), and they also interact whit APC protein in
a region necessary for tumor suppressor activity (37, 38). Furthermore, APC-hDlg
complexes were shown to negatively regulate cell cycle progression in NIH3T3 mouse
fibroblast (39). Therefore, E6-induced degradation of the Dlg1 and Scribble (5) may lead to
decreased APC activity and the nuclear accumulation of β-catenin.
It is difficult to know whether the slight reduction in Dlg1 that was observed in the K14E6
mice (Figure 2) is sufficient to activate Wnt signaling or whether the partial loss of Dlg1
synergizes with the more sharply reduced Scribble protein levels (Figure 2). Other evidence
suggests that the reduction of Dlg1 alone may not lead to β-catenin nuclear accumulation
(39). Therefore, Dlg1 reduction may not be the primary cause of Wnt signaling enhancement
by E6. However, considering current data, we cannot completely discount a potential role
for Dlg1 in Wnt signaling induction (at least in in vivo models). Importantly, in vitro models
may not reflect the mechanisms that occur in vivo. Consistent with these findings, Cavatorta
et al. also reported the presence of only a slight reduction in the hDlg protein in benign
HPV-infected cervical lesions (in which nuclear β-catenin is uncommon), but they reported
a more dramatic reduction in cervical cancers (in which nuclear β-catenin is frequent) (40).
Therefore, low levels of the hDlg protein and nuclear β-catenin may be considered as late-
stage markers in HPV-related carcinogenesis (22, 40).
Short-term in vitro experiments in COS7 cells and primary human foreskin keratinocytes
(Figure 5 and Supplemental Figures 1–2) demonstrated that exogenous expression of the
HPV16-E6 oncoprotein alone only weakly induced Wnt signaling, which was indicated by
TOPFLASH induction, but it demonstrated a significant effect in combination with
exogenous β-catenin or Dvl2 expression. Lichtig et al. reported similar results in HEK293T
cells although their short-term experiments were performed in a Wnt3a-enriched medium.
Therefore, the E6 oncoprotein appears to enhance, but not to initiate Wnt signaling (9).
Consistent with this view, we did not observe any nuclear accumulation of β-catenin in the
young K14E6 animals (Figure 3A).
Concerning the role of the E6 PDZ-binding domain, the discrepancies between our in vitro
and in vivo observations may be due to the use of transient (as opposed to stable)
transfections and by the fact that E6 may alter cellular pathways in younger animals in a
PDZ-independent manner, which is not necessarily represented in short-term cell cultures. In
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this study, we also demonstrate an interaction between E6 and the Dvl2 protein isoform,
which is a key player in both canonical and non-canonical Wnt signaling (Supplemental
Figure 3 and Figure 5B). The in E6 interaction with Dvl2 seems to be independent of its
PDZ-binding domain. This interaction may provide a possible mechanism by which E6
initiates Wnt signaling in a PDZ-independent manner, although the ultimate accumulation
and translocation of β-catenin may require the E6 PDZ-binding domain in vivo.
This work demonstrates for the first time that HPV16-E6 can enhance canonical Wnt
signaling in vivo and in vitro. However, our paradoxical findings regarding the E6’s PDZ-
binding domain suggests that the interaction between E6 and the Wnt pathway is complex,
and it may be dependent on the status of other signaling pathways. The precise mechanism
for Wnt signaling activation remains unknown, and more studies are needed to clarify the
mechanism by which E6 enhances Wnt signaling.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The E6 PDZ-binding domain is essential for maintaining suprabasal cell proliferation
in the adult mouse epidermis
(A) Immunodetection of PCNA, a cell proliferation marker, in the dorsal skin biopsies of 8-
days-old and 4-months-old mice. At 8 days of age, mice expressing either a full-length or
truncated E6 oncoprotein (E6 or E6ΔPDZ) display suprabasal cell proliferation and
hyperplasia compared to non-transgenic (NTG) mice. However, only the mice containing
the complete version of E6 retains suprabasal cell proliferation at 4 months of age.
Therefore, the E6 PDZ-binding domain may exert differential oncogenic effects on adult
skin. (B) Immunodetection of the p53 tumor suppressor protein in 8-days-old mice 8 h after
they were irradiated with 500 mJ/cm2 of UVB. Both forms of the E6 oncoprotein can
degrade the p53 protein, which suggests that the differences in their oncogenic effects are
independent of p53 protein-degradation capacity. Magnification: 40X. Ep = Epidermis.
Dashed line = Basal membrane. Scale bar = 20μm. Arrows = Positive nuclear signal.
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Figure 2. Functional validation of the role of the E6 PDZ-binding domain in adult mice strains
Two PDZ-containing E6 targets (Dlg1 and Scribble) were evaluated in dorsal skin biopsies
from 4-months-old mice by immunohistochemistry (A) or immunoblotting (B). As we show
in graphs, only the K14E6 strain significantly suppressed the Dlg1 or Scribble (Scrib)
proteins compared to K14E6ΔPDZ and the non-transgenic (NTG) mice. Magnification:
40X. Ep = Epidermis. Dashed line = Basal membrane. Scale bar = 20 μm.
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Figure 3. β-catenin nuclear cell accumulation and Wnt signaling induction
Skin tissues from the indicated mice were paraffin embedded. (A) Immunofluorescence
detection of the β-catenin protein was performed in 5-μm-thick dorsal skin samples from
mice of three 3 different ages as indicated. Note that only the K14E6 mice gradually
accumulated nuclear β-catenin, and the highest accumulation occurred at 1 year of age. (B)
Wnt/β-catenin signaling induction was evaluated by the Axin2-dependent expression of
LacZ gene in the skin epithelia of 7-months-old double transgenic mice. Note that only the
Axin2+/LacZ/K14E6 mice show maximal LacZ expression. In (A): Green signal = β-catenin,
Red signal = Propidium Iodide (PI) counterstaining, Yellow signal = Merged signal. In (B):
Blue signal represents LacZ activity, and counterstaining was performed with Fast Red.
Magnification: 40X. Ep = Epidermis. Dashed Line = Basal membrane. Scale bar = 30μm.
Arrows = Positive LacZ nuclear signal.
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Figure 4. The PDZ-binding domain of E6 is necessary to activate β-catenin-responsive genes in
adult dorsal skin
(A) Relative mRNA expression of three Wnt signaling-responsive target genes (ccnd1, c-
myc and birc5) that were evaluated by RT-qPCR. All of the samples were obtained as
described in the methods section. (B) RT-PCR and Western blot of the c-Myc gene in non-
injured skin from the indicated mice, and from wild type-injured skin (positive control).
Note that only the entire E6 protein induces c-Myc protein in a manner that is similar to the
wound stimulus.
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Figure 5. HPV16-E6 enhances canonical Wnt/β-catenin pathway activation and interacts with
the Dvl2 protein independently of the E6 PDZ-binding domain
(A) Wnt/β-catenin pathway activation was assessed using the TOPFLASH construct. COS7
cells were co-transfected with, E6, HPV16-E6Δ141-151 (E6ΔPDZ), Dvl2 and β-catenin (B-
cat) expression vectors. Both full-lenght E6 and E6 lacking the PDZ-binding domain
(E6ΔPDZ) minimally activated the canonical Wnt pathway. Both constructs show very
significant enhancement when co-transfected with Dvl2 or B-cat, which suggests that this
effect was independent of the PDZ-binding domain in our short-term in vitro assays. (B)
COS7 cells were transfected with expression vectors encoding Dvl2, E6 and E6ΔPDZ alone
or in combination. The cells were lysed 24 h after the transfection, and the total cell lysate
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(TCL) was subjected to immunoprecipitation (IP) with an anti-Dvl2 antibody. The
immunoprecipitates were then subjected to SDS-PAGE and blotted with anti-Dvl2 and anti-
AU1 antibodies. Dvl2 was detected at the expected 90-kD size (upper panel). E6 and
E6ΔPDZ, which contain AU1 tags, were detected with the anti-AU1 antibody at the
expected size (18-kD). All of the constructs were expressed at comparable levels. Both, E6
and E6ΔPDZ interact with Dvl2.
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